Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation: The prospective Danish Diet, Cancer and Health study

Thrombosis and Haemostasis

Volumn 112, Issue 4, 2014, Pages 789-795

  Overvad, Thure Filskov ^a,b   Rasmussen, Lars Hvilsted ^a   Skjøth, Flemming ^a,c   Overvad, Kim ^c,d   Albertsen, Ida Ehlers ^b,c   Lane, Deirdre A ^b   Lip, Gregory Y H ^a,b   Larsen, Torben Bjerregaard ^a,c  

^a AALBORG UNIVERSITY   (Denmark)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

Atrial fibrillation; Death; Epidemiology; Sex differences; Stroke; Thromboembolism

Indexed keywords

ARTICLE; CHARLSON COMORBIDITY INDEX; DEATH; HEART ATRIUM FIBRILLATION; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; LIFESTYLE; QUESTIONNAIRE; RISK FACTOR; SEX DIFFERENCE; SYSTEMATIC REVIEW; THROMBOEMBOLISM; AGED; ATRIAL FIBRILLATION; DENMARK; FEMALE; MALE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; REGISTER; THROMBOCYTE;

ANTICOAGULANT AGENT; WARFARIN;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; BLOOD PLATELETS; DENMARK; FEMALE; HUMANS; INCIDENCE; LIFE STYLE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; REGISTRIES; RISK FACTORS; SEX FACTORS; THROMBOEMBOLISM; WARFARIN;

EID: 84908537690     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-06-0545     Document Type: Article

References (38)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-988.
2. Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 2010; 137: 263-272.
3. Wang TJ, Massaro JM, Levy D, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. J Am Med Assoc 2003; 290: 1049-1056.
4. Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Eur Heart J 2012; 33: 2719-2747.
5. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol 2014; Epub ahead of print.
6. You JJ, Singer DE, Howard PA, et al. Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141: e531S-575S.
7. Wagstaff AJ, Overvad TF, Lip GY, et al. Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis. QJM 2014; Epub ahead of print.
8. Mikkelsen A, Lindhardsen J, Lip GY, et al. Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study. J Thromb Haemost 2012; 10: 1745-1751.
9. Tsadok MA, Jackevicius CA, Rahme E, et al. Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. J Am Med Assoc 2012; 307: 1952-1958.
10. Friberg L, Benson L, Rosenqvist M, et al. Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study. Br Med J 2012; 344: e3522.
11. Cove CL, Albert CM, Andreotti F, et al. Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms. Thromb Haemost 2014; 111: 385-391.
12. Zhang Y, Tuomilehto J, Jousilahti P, et al. Lifestyle factors on the risks of ischaemic and hemorrhagic stroke. Arch Intern Med 2011; 171: 1811-1818.
13. Tjønneland A, Olsen A, Boll K, et al. Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57, 053 men and women in Denmark. Scand J Public Health 2007; 35: 432-441.
14. Thygesen LC, Daasnes C, Thaulow I, et al. Introduction to Danish (nationwide) registers on health and social issues: Structure, access, legislation, and archiving. Scand J Public Health 2011; 39: 12-16.
15. Rix TA, Riahi S, Overvad K, et al. Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry. Scand Cardiovasc J 2012; 46: 149-153.
16. Overvad K, Tjønneland A, Haraldsdóttir J, et al. Development of a semiquantitative food frequency questionnaire to assess food, energy and nutrient intake in Denmark. Int J Epidemiol 1991; 20: 900-905.
17. Tjønneland A, Overvad K, Haraldsdóttir J, et al. Validation of a semiquantitative food frequency questionnaire developed in Denmark. Int J Epidemiol 1991; 20: 906-912.
18. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
19. Thygesen SK, Christiansen CF, Christensen S, et al. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 2011; 11: 83.
20. Abildstrøm SZ, Torp-Pedersen C, Madsen M. Register-based studies of cardiovascular disease. Scand J Public Health 2011; 39: 165-169.
21. Albertsen IE, Rasmussen LH, Lane DA, et al. The impact of smoking on thromboembolism and mortality in patients with incident atrial fibrillation: insights from the Danish Diet, Cancer, and Health study. Chest 2014; 145: 559-566.
22. Overvad TF, Rasmussen LH, Skjøth F, et al. Alcohol intake and prognosis of atrial fibrillation. Heart 2013; 99: 1093-1099.
23. Overvad TF, Rasmussen LH, Skjøth F, et al. Body mass index and adverse events in patients with incident atrial fibrillation. Am J Med 2013; 126: 640. e9-640. e17.
24. Pancholy SB, Sharma PS, Pancholy DS, et al. Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants. Am J Cardiol 2014; 113: 485-490.
25. Hobbs FD, Roalfe AK, Lip GY, et al. Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial. Br Med J 2011; 342: d3653.
26. Kimura K, Minematsu K, Yamaguchi T. Atrial fibrillation as a predictive factor for severe stroke and early death in 15, 831 patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2005; 76: 679-683.
27. Lin HJ, Wolf PA, Kelly-Hayes M, et al. Stroke severity in atrial fibrillation: the Framingham Study. Stroke 1996; 27: 1760-1764.
28. Fang MC, Singer DE, Chang Y, et al. Gender differences in the risk of ischaemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study. Circulation 2005; 112: 1687-1691.
29. Hart RG, Pearce LA, McBride R, et al. Factors associated with ischaemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. Stroke 1999; 30: 1223-1229.
30. Nelson HD, Walker M, Zakher B, et al. Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U. S. Preventive Services Task Force recommendations. Ann Intern Med 2012; 157: 104-113.
31. Magliano DJ, Rogers SL, Abramson MJ, et al. Hormone therapy and cardiovascular disease: a systematic review and meta-analysis. Br J Obstet Gynecol 2006; 113: 5-14.
32. Schierbeck LL, Rejnmark L, Tofteng CL, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. Br Med J 2012; 345: e6409.
33. Johnsen SP, Overvad K, Sørensen HT, et al. Predictive value of stroke and transient ischaemic attack discharge diagnoses in the Danish National Registry of Patients. J Clin Epidemiol 2002; 55: 602-607.
34. Helweg-larsen K. The Danish Register of Causes of Death. Scand J Public Health 2011; 39: 26-29.
35. Banerjee A, Taillandier S, Olesen JB, et al. Pattern of atrial fibrillation and risk of outcomes: The Loire Valley Atrial Fibrillation Project. Int J Cardiol 2013; 167: 2682-2687.
36. De Caterina R, Husted S, Wallentin L, et al. Vitamin K antagonists in heart disease: Current status and perspectives (Section III). Position Paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thromb Haemost 2013; 110: 1087-1107.
37. Sullivan RM, Zhang J, Zamba G, et al. Relation of gender-specific risk of ischaemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM). Am J Cardiol 2012; 110: 1799-1802.
38. Guo Y, Wang H, Zhao X, et al. Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation. Int J Cardiol 2013; 168: 1502-1508.